FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer
FGFR1 扩增介导转移性激素受体阳性 (HR+) 乳腺癌的内分泌抵抗但保留了 TORC 敏感性
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-19-0138
Joshua Z Drago #, Luigi Formisano #, Dejan Juric, Andrzej Niemierko, Alberto Servetto, Seth A Wander, Laura M Spring, Neelima Vidula, Jerry Younger, Jeffrey Peppercorn, Megan Yuen, Giuliana Malvarosa, Dennis Sgroi, Steven J Isakoff, Beverly Moy, Leif W Ellisen, A John Iafrate, Carlos L Arteaga #, Ad